A new report by Access Economics confirms spending on the Pharmaceutical Benefits Scheme operated in Australia will not spiral out of control, as the former John Howard government's two intergenerational reports predicted. The new study was presented on April 2.
Pharmaceutical body Medicines Australia's chief executive, Ian Chalmers, said the report demonstrates very clearly that the PBS will be sustainable into the future and will not blow out government health care budgets.
"This important study presents a powerful argument to the Rudd government as to why the PBS should be quarantined from budget cuts," Mr Chalmers noted. "We now have compelling independent evidence that growth is being contained and we have a sustainable PBS," he said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze